Completed PHASE2 INTERVENTIONAL 1-arm NCT01292356

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

Sponsor: Poitiers University Hospital

Interventions cetuximab

Updated 6 times since 2017 Last updated: Apr 4, 2017 Started: Dec 20, 2010 Primary completion: Mar 3, 2016 Completion: Mar 3, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metastatic Colon Cancer, this trial is completed. The trial is conducted by Poitiers University Hospital and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Recruiting PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Poitiers University Hospital

Data source: Poitiers University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Poitiers, France